Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03428373
Title ASA vs. Rivaroxaban in Newly Diagnosed or Relapsed and Refractory Multiple Myeloma Patients Treated With Len-Dex Combination Therapy. (RithMM)
Acronym RithMM
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Lawson Health Research Institute
Age Groups: senior | adult
Covered Countries CAN

No variant requirements are available.